From Chairman�s Desk

doi:10.18579/jpcrkc/2011/10/2/89026

Article

VIEWS 1225
PDF 247

Journal of Pharmaceutical Research

DOI: 10.18579/jpcrkc/2011/10/2/89026

Year: 2011, Volume: 10, Issue: 2, Pages:

Original Article

From Chairman�s Desk

This work is licensed under a Creative Commons Attribution 4.0 International License.

Abstract

No Abstract.

Year: 2011, Volume: 10, Issue: 2

Original Article A Review on Extended Release Matrix Tablet

A Review on Extended Release Matrix Tablet

Purpose : The aim of the study was to explore the necessity, advantages and different techniques of extended release matrix tab...

Original Article Prescribing Pattern of Hypertensive Medications in Elderly Patients with Diabetes Mellitus

Prescribing Pattern of Hypertensive Medications in Elderly Patients...

Objective:To assess the pattern of prescribing for elderly patients who were suffering from hypertension and type-2 diabetes me...

Original Article Severe Anaphylaxis with Oxaliplatin Therapy in a Patient with Colon Cancer: A Case Report

Severe Anaphylaxis with Oxaliplatin Therapy in a Patient with Colon...

Oxaliplatin is a third-generation platinum analogue that is mainly used in the treatment of advanced colorectal cancer. The rep...

Original Article Evaluation of Kidney Function in Bipolar Patients: A Cross-Sectional Study

Evaluation of Kidney Function in Bipolar Patients: A Cross-Sectiona...

Bipolar disorder is a chronic disease that represents a significant problem to the affected individual. To date, the ...

Original Article LC–MS/MS Determination of Prednisone, A Drug in Phase 4 of Multiple Sclerosis Therapy along with Teriflunomide and Pioglitazone in Rat Plasma

LC–MS/MS Determination of Prednisone, A Drug in Phase 4 of Multip...

Combination therapy or polytherapy is that uses more than one medication to treat a single disease and associated dis...

Original Article Formulation and Evaluation of Lansoprazole Floating Tablets

Formulation and Evaluation of Lansoprazole Floating Tablets

Floating tablets were designed to prolong the gastric residence time after oral administration and to achieve controlled releas...

Original Article Oxaliplatin-Induced Dysphonia and Dysarthria - A Case Report

Oxaliplatin-Induced Dysphonia and Dysarthria - A Case Report

Oxaliplatin is a new, third-generation platinum complex. It has a good safety profile characterized by low haematological-gastr...

Original Article Octreotide in Management of Diarrhoea in Human Immunodeficiency Syndrome Patients

Octreotide in Management of Diarrhoea in Human Immunodeficiency Syn...

Octreotide is a long acting somatostatin analogue mainly used as the first line agent in the management of oesophageal variceal...

Original Article Estimation of Nateglinide and Metformin Hydrochloride in Tablet Dosage form by Spectrophotometric Methods

Estimation of Nateglinide and Metformin Hydrochloride in Tablet Dos...

Three UV spectrophotometric methods have been developed for the simultaneous estimation of Nateglinide (Nat) and Metformin hydr...

Original Article Screening the Influence of Comorbidities Treatment on Diabetes Management

Screening the Influence of Comorbidities Treatment on Diabetes Mana...

Purpose of the Study :Diabetics is a chronic metabolic disorder associated with high blood glucose level, it causes various co-...

Journal of Pharmaceutical Research

Article

From Chairman�s Desk

Abstract

How to cite this paper

More articles

A Review on Extended Release Matrix Tablet

Prescribing Pattern of Hypertensive Medications in Elderly Patients...

Severe Anaphylaxis with Oxaliplatin Therapy in a Patient with Colon...

Evaluation of Kidney Function in Bipolar Patients: A Cross-Sectiona...

LC–MS/MS Determination of Prednisone, A Drug in Phase 4 of Multip...

Formulation and Evaluation of Lansoprazole Floating Tablets

Oxaliplatin-Induced Dysphonia and Dysarthria - A Case Report

Octreotide in Management of Diarrhoea in Human Immunodeficiency Syn...

Estimation of Nateglinide and Metformin Hydrochloride in Tablet Dos...

Screening the Influence of Comorbidities Treatment on Diabetes Mana...

DON'T MISS OUT!